Sign inGet started

GV 2016, L.P.

Insider CIK 1721789 · ASNS 10% owner · STCB 10% owner · DBTX 10% owner · MGTA 10% owner · ARMO 10% owner · RCUS 10% owner · IONQ 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
STCB Starco Brands, Inc. J Other2025-05-152025-05-1947,980,156— $0147,490,961SEC↗
STCB Starco Brands, Inc. J Other2024-02-152025-02-1336,300,393— $099,510,805SEC↗
STCB Starco Brands, Inc. J Other2024-02-142025-02-135,675,399— $063,210,412SEC↗
IONQ IonQ, Inc. S Sale2022-04-112022-04-12539,257$11.16 $6.02M4,992SEC↗
IONQ IonQ, Inc. J Other2022-04-112022-04-122,642,573— $014,707,933SEC↗
IONQ IonQ, Inc. S Sale2022-04-112022-04-124,992$11.83 $59.1K0SEC↗
DBTX Decibel Therapeutics, Inc. C Conversion deriv2021-02-172021-02-175,000,000— $00SEC↗
DBTX Decibel Therapeutics, Inc. C Conversion2021-02-172021-02-17321,978— $0321,978SEC↗
MGTA Magenta Therapeutics, Inc. C Conversion deriv2018-06-252018-06-278,494,864— $00SEC↗
MGTA Magenta Therapeutics, Inc. C Conversion deriv2018-06-252018-06-27133,400— $00SEC↗
MGTA Magenta Therapeutics, Inc. C Conversion2018-06-252018-06-273,339,137— $03,339,137SEC↗
RCUS Arcus Biosciences, Inc. C Conversion deriv2018-03-192018-03-193,125,312— $00SEC↗
RCUS Arcus Biosciences, Inc. C Conversion2018-03-192018-03-193,125,312— $03,125,312SEC↗
ARMO ARMO BioSciences, Inc. C Conversion deriv2018-01-302018-01-30607,350— $00SEC↗
ARMO ARMO BioSciences, Inc. C Conversion2018-01-302018-01-30607,350— $0607,350SEC↗
ASNS Arsanis, Inc. C Conversion deriv2017-11-202017-11-201,540,499— $00SEC↗
ASNS Arsanis, Inc. C Conversion2017-11-202017-11-20451,362— $0451,362SEC↗